In this study, the effects of Pulmozyme®, a pharmaceutical composition containing human recombinant DNase I, on the proliferation and cell migration in vitro and metastases development in a B16 melanoma model in vivo were investigated. The gene discussed is DNASE1; the disease is melanoma.